NCT05487222

Brief Summary

The aim is to compare intraoperative goal directed fluid therapy (GDFT) versus liberal fluid therapy in patients undergoing elective colorectal surgery by using noninvasive electrical cardiometry. This study hypothesized that GDFT is better than liberal fluid therapy to provide sufficient intra-vascular fluid volume for adequate perfusion without impairing glycolcalyx function with fluid overload

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 10, 2020

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2021

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 20, 2021

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

December 28, 2021

Completed
7 months until next milestone

First Posted

Study publicly available on registry

August 4, 2022

Completed
Last Updated

August 4, 2022

Status Verified

August 1, 2022

Enrollment Period

1.4 years

First QC Date

December 28, 2021

Last Update Submit

August 2, 2022

Conditions

Keywords

fluid therapy, goal directed , liberal , colorectal surgery

Outcome Measures

Primary Outcomes (1)

  • serum creatinine level

    mg/dl

    24 hours postoperative

Secondary Outcomes (5)

  • stroke volume (SV)

    Basal preoperative, before induction of anesthesia (T1), just before skin incision (T2), then every 30 min until end of surgery then every 6 hour for 24 hours

  • stroke volume variation (SVV)

    Basal preoperative, before induction of anesthesia (T1), just before skin incision (T2), then every 30 min until end of surgery then every 6 hour for 24 hours

  • stroke volume index (SVI)

    Basal preoperative, before induction of anesthesia (T1), just before skin incision (T2), then every 30 min until end of surgery then every 6 hour for 24 hours

  • cardiac index

    Basal preoperative, before induction of anesthesia (T1), just before skin incision (T2), then every 30 min until end of surgery then every 6 hour for 24 hours

  • cardiac output (COP)

    Basal preoperative, before induction of anesthesia (T1), just before skin incision (T2), then every 30 min until end of surgery then every 6 hour for 24 hours

Study Arms (2)

• Liberal fluid group (L group) using traditional technique of fluid administration

Device: ICON

• Goal directed fluid group(G group) using stroke volume optimization

Device: ICON

Interventions

ICONDEVICE

hemodynamics variability in response to different fluid regiemens

• Goal directed fluid group(G group) using stroke volume optimization• Liberal fluid group (L group) using traditional technique of fluid administration

Eligibility Criteria

Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

This prospective, randomized, controlled study was conducted after a written informed consent will be obtained from all participants

You may qualify if:

  • patients scheduled for elective colorectal surgery
  • with (ASA) physical status I - II - of both gender aged 18-60 years old
  • Hb \>12 g/dl \& Hct \>38%.

You may not qualify if:

  • Patient refusal
  • Patients with major cardiovascular problems with ejection fraction \< 40 %
  • Renal impairment with serum creatinine \>1.8 mg/dl .
  • Patients with hepatic dysfunction and coagulopathy.
  • Metabolic disorder, serum lactate \> 4 mmol/L.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mansoura Oncology Center

Al Mansurah, Eldakahlia, Egypt

Location

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor

Study Record Dates

First Submitted

December 28, 2021

First Posted

August 4, 2022

Study Start

January 10, 2020

Primary Completion

June 15, 2021

Study Completion

September 20, 2021

Last Updated

August 4, 2022

Record last verified: 2022-08

Locations